获取途径

作者

Chuan Li, Dan-Ping Zhu, Jia Chen, Xiao-Yu Zhu, Nai-Nong Li, Wei-Jie Cao, Zhong-Ming Zhang, Ye-Hui Tan, Xiao-Xia Hu, Hai-Long Yuan, Xiao-Sheng Fang, Yue Yin, Hong-Tao Wang, Nan Li, Xiao-Jun Huang, Yu-Qian Sun

作者单位

Affiliations ¹ Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China. ² The First Affiliated Hospital of Soochow University, Suzhou, China. ³ Department of Hematology, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China. ⁴ Hematopoietic Stem Cell Transplantation Center, Fujian Institute of Hematology, Fujian Provincial Key Laboratory on Hematology, Department of Hematology, Fujian Medical University Union Hospital, Fuzhou, China. ⁵ Department of Hematology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China. ⁶ The first affiliated hospital of Guangxi Medical University, Nanning, China. ⁷ Department of Hematology, The First Affiliated Hospital of Jilin University, Changchun, China. ⁸ State Key Laboratory of Medical Genomics, Shanghai Institute of Hematology, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. ⁹ The First Affiliated Hospital of Xinjiang Medical University, Xinjiang Institute of Hematology, Urumqi, China. ¹⁰ Shandong First Medical University Affiliated Provincial Hospital, Jinan, China. ¹¹ Peking University First Hospital, Beijing, China. ¹² Department of Hematology, Shengjing Hospital of China Medical University, Shenyang, China. ¹³ Research Center of Clinical Epidemiology, Peking University Third Hospital, Beijing, China.

刊名

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

年份

2024

页码

ciae612

ISSN

1537-6591

关键词

Allogeneic stem cell transplantation (allo-HSCT) China Invasive fungal disease (IFD).

摘要

Background: This study aimed to provide updated epidemiological data on invasive fungal disease in patients undergoing allogeneic stem cell transplantation . Methods: This multicenter, real-world, observational study was conducted at 12 allo-HSCT centers in China between January 2021 and December 2021. Consecutive adult patients who underwent allo-HSCT with antifungal prophylaxis were included. IFD was diagnosed according to the 2019 criteria of the European Organization for Research and Trea...更多

Background: This study aimed to provide updated epidemiological data on invasive fungal disease in patients undergoing allogeneic stem cell transplantation . Methods: This multicenter, real-world, observational study was conducted at 12 allo-HSCT centers in China between January 2021 and December 2021. Consecutive adult patients who underwent allo-HSCT with antifungal prophylaxis were included. IFD was diagnosed according to the 2019 criteria of the European Organization for Research and Treatment of Cancer and Mycoses Study Group . Follow-up was completed by December 31, 2022. Results: A total of 2015 patients were collected. mold-active antifungal prophylaxis was used in 76.08% of patients, which included mainly voriconazole and posaconazole . The cumulative incidence of IFD at 1 year after allo-HSCT was 6.3%. Pathogens were identified in 47.97% of IFD cases and mainly included Candida spp. , Mucorales , Aspergillus spp. , and Pneumocystis jirovecii . Multivariate analysis identified the following factors associated with IFD: disease at advanced stage , absolute neutrophil count engraftment , platelet engraftment and acute graft-versus-host disease grade III-IV . The IFD-attributable mortality rate was 48.28%. Conclusions: Despite the widespread use of mold-active prophylaxis, the risk of IFD after allo-HSCT remains high. The most common pathogens are Candida spp., Mucorales, Aspergillus spp., and Pneumocystis jirovecii.收起

文献类型

期刊